- Jim Minow, Executive Director of Cure JM
- Andrew Heaton, PhD, Chief Science Officer
- Shannon Malloy, Director of Development and Family Engagement
Juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis, is a group of rare and life-threatening autoimmune diseases, in which the body’s immune system attacks its own cells and tissues.
A treatment plan is based on many factors, including the severity and expression of the juvenile dermatomyositis (JDM). Each case is different and the symptoms can change over time.
In speaking with JM families, we’ve identified seven “best practices” that are absolutely crucial when you, your child and family are battling juvenile myositis.
Membership is free and we’ll connect you with a network of support, encouragement, and resources.